Skip to main content
FinSpry Logo
FinSpry
IMVT logo
IMVT
(NASDAQ)
Immunovant, Inc.
$39.37-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Immunovant (IMVT) Stock Price & Financial Analysis

Immunovant Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$38.00 - $39.60
52-Week High$41.23
52-Week Low$14.32
Open$38.39
Volume784.11K
Average Volume (3M)1.41M
Market Cap8.02B
Shares Outstanding203.71M
Price to Book (P/B)9.41
EV/EBITDA-13.75
50-Day MA$35.20
200-Day MA$27.38
52-Week Change114.08%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immunovant

What is the current stock price for IMVT?

As of the latest trading session, IMVT stock trades at $39.37. The 52-week range is $14.32–$41.23, with a day range of $38.00–$39.60.

What is the P/E ratio for IMVT?

The P/E ratio (Price-to-Earnings) for IMVT is shown in the Key Statistics section. This valuation metric helps compare Immunovant, Inc. to industry peers.

Does IMVT pay dividends?

Immunovant does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMVT?

Based on 15 analysts, the consensus for IMVT is Buy.

What is the market cap of IMVT?

Immunovant's market capitalization is $8.02B, classifying it as a mid-cap company. Immunovant operates in the Healthcare sector within the Biotechnology industry.